Science Explorer Back to mapMap
Discussion
Researcher · Hochgebirgsklinik Davos · Switzerland

Michael Schmitz-Schumann

Michael Schmitz-Schumann publishes mostly in Physiology, Pharmacology and Pulmonary and Respiratory Medicine, on topics such as Asthma and respiratory diseases, Drug-Induced Adverse Reactions and Inflammatory mediators and NSAID effects.

OpenAlex
World rank
#3,150,706
of 7,710,434 ranked researchers
Rank in Switzerland
#46,342
of 80,918
Works
41
Citations
1k
Citations per work
24.5
h-index
16
i10-index 19Top 35% in Physiology (Medicine)
Michael Schmitz-Schumann

What does Michael Schmitz-Schumann research?

Michael Schmitz-Schumann's work is mostly in Medicine (67%), Immunology and Microbiology (3%), Agricultural and Biological Sciences (2%).

Health Sciences: 28 works · 67.1% of their workMedicine: 28 works · 67.1% of their workPhysiology: 9 works · 23.1% of their workPharmacology: 9 works · 20.9% of their workPulmonary and Respiratory Medicine: 8 works · 19.8% of their workImmunology and Allergy: 1 works · 3.3% of their workEverything else: 11 works · 27.4% of their workLife Sciences: 2 works · 5.5% of their workImmunology and Microbiology: 1 works · 3.3% of their workImmunology: 1 works · 3.3% of their workAgricultural and Biological Sciences: 1 works · 2.2% of their workPlant Science: 1 works · 2.2% of their workTHEIR WORKMichaelSchmitz-Schumann41works
Life Sciences6%Health Sciences67%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2867.1%
  2. Everything else1127.4%
    1. Immunology and Microbiology13.3%
    2. Agricultural and Biological Sciences12.2%
  1. 1Physiology23% of their works
  2. 2Pharmacology21% of their works
  3. 3Pulmonary and Respiratory Medicine20% of their works
  4. 4Immunology and Allergy3% of their works
  5. 5Immunology3% of their works
  6. 6Plant Science2% of their works

Research topics

Which keywords describe Michael Schmitz-Schumann's research?

The keywords of their largest research topics: Inflammation, Asthma, Genetics, Allergic Diseases, Eosinophils, HLA-B*5701, Stevens-Johnson Syndrome and Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Inflammation262 topics
  2. Asthma212 topics
  3. Genetics212 topics
  4. Allergic Diseases191 topic
  5. Eosinophils191 topic
  6. HLA-B*5701121 topic
  7. Stevens-Johnson Syndrome121 topic
  8. Cancer71 topic
  9. Cyclooxygenase-2 Inhibitors71 topic
  10. Inhaler Devices61 topic
  11. Pulmonary Drug Delivery61 topic
  12. Chronic Cough41 topic
  13. Cough Reflex Sensitivity41 topic
  14. Allergen-specific Immunotherapy21 topic
  15. Complement21 topic
  16. Hereditary Angioedema21 topic
  17. Immune21 topic
  18. Kinin Receptor Family21 topic
  19. Pollen Allergy21 topic

Where does Michael Schmitz-Schumann work?

Michael Schmitz-Schumann's main affiliation in the publication record is Hochgebirgsklinik Davos, Switzerland.

How many publications and citations does Michael Schmitz-Schumann have?

OpenAlex counts 41 works and 1,006 citations for Michael Schmitz-Schumann, an h-index of 16, ranking #3,150,706 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael Schmitz-Schumann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.